Abstract
Short-term trials involving adults with ADHD have shown significant improvements in symptoms with stimulants and atomoxetine; however, data on long-term benefits and risks of these medications, particularly among older persons, have been insufficient.
MeSH terms
-
Adrenergic Uptake Inhibitors / therapeutic use
-
Adult
-
Atomoxetine Hydrochloride
-
Attention Deficit Disorder with Hyperactivity* / diagnosis
-
Attention Deficit Disorder with Hyperactivity* / etiology
-
Attention Deficit Disorder with Hyperactivity* / therapy
-
Central Nervous System Stimulants / therapeutic use*
-
Cognitive Behavioral Therapy
-
Female
-
Humans
-
Practice Guidelines as Topic
-
Propylamines / therapeutic use
Substances
-
Adrenergic Uptake Inhibitors
-
Central Nervous System Stimulants
-
Propylamines
-
Atomoxetine Hydrochloride